Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
×

Get our Best Content in Your Email

You are already a member! Please enter your password to sign in.

CSE New Listing - Phivida Holdings Commences Trading on the Canadian Securities Exchange - Video News Alert on Investmentpitch.com

C.VIDA

Vancouver, British Columbia--(Newsfile Corp. - December 22, 2017) - Phivida Holdings (CSE: VIDA) is the latest new listing on the Canadian Securities Exchange, trading under the symbol "VIDA".

InvestmentPitch Media has produced a "video" which provides a brief overview of the company. If this link is not enabled, please visit www.InvestmentPitch.com and enter "Phivida" in the search box.



Cannot view this video? Visit:
http://www.investmentpitch.com/video/0_gb9wte86/Phivida-Holdings-CSE-VIDA-New-Listing

The company raised gross proceeds of $5,750,000 by way of a prospectus offering of 14,375,000 units, including the over-allotment, priced at $0.40 per unit. Each unit consisted of 1 share and one-half a warrant, with each full warrant exercisable at $0.75 for 24 months, subject to an acceleration clause.

Canaccord Genuity acted as lead agent, along with Mackie Research Capital and Haywood Securities as agents for the offering. The company intends to use the proceeds from the offering to begin full-scale manufacturing, marketing and distribution of Phivida Nutrition and Phivida Enhanced products.

Phivida Nutrition products will consist of custom formulated hemp oil infused beverages that include a proprietary blend of nutraceuticals and infused with nanoencapsulated hemp oil extracts. Phivida Enhanced products will be marketed under the Vida+ brand name as functional foods and supplement nutraceuticals and capture a share of the US CBD hemp oil market.

John-David Belfontaine, CEO, stated: "The clinical research on cannabinoids has already captured the attention of health care practitioners, regulators, professional athletes and the media, which is why investors are so keenly interested in the industry. One of the factors that sets Phivida apart is our unwavering support for research and education into this important field of health and wellness, and our commitment to apply what we learn to benefit families."

The shares are trading at $1.15, and with 27.1 million shares outstanding, the company is capitalized at $31.2 million.

For more information, please visit the company's website www.phivida.com, contact John-David Belfontaine, CEO, at 1-844-744-6646 (ext 32) or email IR@phivida.com.

About InvestmentPitch Media

InvestmentPitch Media leverages the power of video, which together with its extensive distribution, positions a company's story ahead of the 1,000's of companies seeking awareness and funding from the financial community. The company specializes in producing short videos based on significant news releases, research reports and other content of interest to investors.

CONTACT:
InvestmentPitch Media
Barry Morgan, CFO
bmorgan@investmentpitch.com

Tags:

Rate this press release
3 stars
v
Usefulness

Clarity

Credibility